Research Articles | Page 80 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Poly (ADP-ribose) polymerase 1 mRNA levels strongly correlate with the prognosis of myelodysplastic syndromes. Feb 2017 Blood Cancer J myelodysplastic syndromes (MDS)
Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria Sep 2013 Haematologica paroxysmal nocturnal hemoglobinuria (PNH)
Polymorphisms of Interlukin-1β rs16944 confer susceptibility to myelodysplastic syndromes Nov 2016 Life Sci. myelodysplastic syndromes (MDS)
Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation. May 2017 Bone Marrow Transplant aplastic anemia
Positive Impact of Eculizumab Therapy on Surgery for Budd-Chiari Syndrome in a Patient with Paroxysmal Nocturnal Hemoglobinuria and a Long-Term History of Thrombosis Sep 2016 Hematol Rep paroxysmal nocturnal hemoglobinuria (PNH)
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantat Feb 2021 Journal for immunotherapy of cancer myelodysplastic syndromes (MDS)
Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag Apr 2021 Haematologica aplastic anemia
Prediction of adverse events during Intensive Induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes Jan 2014 Am J Hematol myelodysplastic syndromes (MDS)
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria Oct 2023 Annals of Hematology paroxysmal nocturnal hemoglobinuria (PNH)
Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia Aug 2017 Ann Hematol aplastic anemia
Share with addtoany.com.